Zinc Levels May Predict Worse Outcomes With Alopecia

This article originally appeared here.
Share this content:
Zinc Levels May Predict Worse Outcomes With Alopecia
Zinc Levels May Predict Worse Outcomes With Alopecia

FRIDAY, July 10, 2015 (HealthDay News) -- Lower serum zinc levels are associated with worse outcomes in patients with alopecia areata, according to a study published online July 3 in the International Journal of Dermatology.

Nermeen S.A. Abdel Fattah, M.D., from Ain Shams University in Cairo, and colleagues compared serum zinc levels between patients with newly diagnosed (25 participants) and resistant lesions of alopecia areata (25 participants) and in age- and sex-matched healthy controls (50 participants).

The researchers found that patients with alopecia areata had significantly lower serum zinc levels, compared to controls. Patients with resistant alopecia areata also had significantly lower zinc levels compared to patients with newly diagnosed disease. There was a significant inverse correlation between serum zinc level, severity of disease, and disease duration in all patients, as well as in patients with resistant alopecia areata.

"Assessment of serum zinc level in patients with alopecia areata appears useful as a marker of severity, disease duration, and resistance to therapies," the authors write. "Further studies are therefore recommended to evaluate the role of zinc supplements in patients with alopecia areata, especially those with severe, longstanding, or resistant lesions."

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

FDA Permits Marketing of Brain Stimulation Device for OCD

FDA Permits Marketing of Brain Stimulation Device for ...

FDA previously approved transcranial magnetic stimulation for major depression, certain migraines

Comments Open on End of NIH Review for Gene Therapy Studies

Comments Open on End of NIH Review for ...

NIH oversight panel no longer plans to review all applications for gene therapy experiments

U.S. Measles Outbreak Hits 107 Cases in 21 States, D.C.

U.S. Measles Outbreak Hits 107 Cases in 21 ...

Outbreak on track to exceed last year's; most of the people who got measles weren't vaccinated

is free, fast, and customized just for you!




Already a member?

Sign In Now »